Omeros Corporation
NASDAQ:OMERBiotechnology
+$0.43 today
- Market cap
- $1.08B
- Beta
- 2.53
- P/E (TTM)
- 8.4
- EPS (TTM)
- $1.20
Volume 2.53M
Average 1.55M
OMER Other Income / Expenses
Net non-operating gains and losses, such as investment results, currency effects, and one-off items.
Omeros CorporationNASDAQ: OMER
Other Income / Expenses · Q1 FY2026 · quarter ended Mar 2026
Other income / expenses turns positive
Q1 FY2026 other income / expenses was $68.73M, compared with -$2.6M a year earlier. Trailing-twelve-month other income / expenses was $191.32M.
Context
- Other income / expenses increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly other income / expenses holds near $68.73M or moves back toward the trailing-twelve-month quarterly average of $47.83M.
Sources:Income StatementText generated from reported figures; not investment advice.
Other Income / Expenses history
USD · from the income statement
- Latest · FY2025
- 120M USD
- Year-over-year change
- +997.5%
| Period | Period end | Other Income / Expenses | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 120M | +997.5% |
| FY2024 | 2024-12-31 | (13.37M) | -28.7% |
| FY2023 | 2023-12-31 | (10.39M) | +44.3% |
| FY2022 | 2022-12-31 | (18.64M) | -4.0% |
| FY2021 | 2021-12-31 | (17.93M) | — |
Other Income / Expenses vs competitors
How OMER compares with its peers on the latest reported figures
- OMER's LTM Mar 2026 other income / expenses of $191.32M is the highest of the 11 companies compared; the peer median is $2.81M.
- Its year-over-year change of +1815.8% is the highest of 11, against a peer median of -18.1%.
- Other income / expenses amounts to 1933.9% of revenue for OMER, versus a peer median of 29.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $191.32M | +1815.8% | — | 1933.9% | |
| LTM Jun 2026 | $55.23M | +206.4% | +46.5% | 52.6% | |
| LTM Jun 2026 | $34M | +6.3% | +33.1% | 29.1% | |
| LTM Mar 2026 | $19.31M | -36.3% | +48.3% | — | |
| LTM Mar 2026 | $4.18M | -19.6% | +32.8% | 5.8% | |
| LTM Mar 2026 | $3.76M | +136.9% | — | — | |
| LTM Mar 2026 | $1.86M | +124.8% | — | 372.3% | |
| LTM Mar 2026 | -$7.37M | -116.5% | — | 4.7% | |
| LTM Jun 2026 | -$18.16M | -151.5% | — | — | |
| LTM Jun 2026 | -$25.52M | -16.6% | — | 46.8% | |
| LTM Mar 2026 | -$67.43M | -67.3% | — | 29.0% | |
| Peer median (excluding OMER) | $2.81M | -18.1% | +39.8% | 29.1% | |
Competitors are the stored peer set for OMER. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 1.39M | 0 | 0 | 0 | 0 |
| Gross Profit | (1.39M) | 0 | 0 | 0 | 0 |
| Gross Margin | — | — | — | — | — |
| Research & Development | 118.78M | 112.72M | 114.87M | 119.52M | 81.3M |
| Selling, General & Admin | 53.46M | 50.67M | 49.66M | 49.74M | 41.5M |
| Operating Expenses | 172.23M | 163.39M | 164.53M | 169.26M | 122.8M |
| Depreciation & Amortization | 1.39M | 952K | 920K | 950K | 964K |
| EBITDA | (170.49M) | (158.38M) | (143.16M) | (157M) | (1.83M) |
| EBITDA Margin | — | — | — | — | — |
| Operating Income | (173.62M) | (163.39M) | (164.53M) | (169.26M) | (122.8M) |
| Operating Margin | — | — | — | — | — |
| Interest Income | 17.93K | 4.06M | 16.34M | 11.3M | 5.06M |
| Interest Expense | 19.67M | 22.7M | 30.84M | 24.68M | 0 |
| Other Income / Expenses | (17.93M) | (18.64M) | (10.39M) | (13.37M) | 120M |
| Income Before Tax | (191.55M) | (182.03M) | (174.92M) | (182.63M) | (2.8M) |
| Pre-Tax Margin | — | — | — | — | — |
| Income Tax Expense | 0 | 0 | 0 | 0 | 2.01M |
| Net Income | (111.41M) | 47.42M | (117.81M) | (156.82M) | (3.35M) |
| Net Margin | — | — | — | — | — |
| EPS (Basic) | 3.12 | 0.46 | (1.88) | (2.70) | (0.05) |
| EPS (Diluted) | 3.12 | 0.46 | (1.88) | (2.70) | (0.05) |
| Weighted Avg Shares | 62.34M | 62.74M | 62.74M | 58.17M | 63.51M |
| Weighted Avg Shares (Diluted) | 62.34M | 62.74M | 62.74M | 58.17M | 63.51M |
Omeros Corporation
NASDAQ:OMER
Intrinsic Alpha fair value
Locked
Current Price
$14.55
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.